MedPath

Calcium

Generic Name
Calcium
Drug Type
Small Molecule
Chemical Formula
Ca
CAS Number
7440-70-2
Unique Ingredient Identifier
SY7Q814VUP
Background

Calcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. The skeleton acts as a major mineral storage site for the element and releases Ca2+ ions into the bloodstream under controlled conditions. Circulating calcium is either in the free, ionized form or bound to blood proteins such as serum albumin. Although calcium flow to and from the bone is neutral, about 5 mmol is turned over a day. Bone serves as an important storage point for calcium, as it contains 99% of the total body calcium. Low calcium intake may also be a risk factor in the development of osteoporosis. The best-absorbed form of calcium from a pill is a calcium salt like carbonate or phosphate. Calcium gluconate and calcium lactate are absorbed well by pregnant women. Seniors absorb calcium lactate, gluconate and citrate better unless they take their calcium supplement with a full breakfast.

Indication

Calcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. It is vital in cell signaling, muscular contractions, bone health, and signalling cascades.

Associated Conditions
Calcium Deficiency, Deficiency, Vitamin D, Osteodystrophy, Osteomalacia, Osteoporosis, Chronic Hypocalcemia, Chronic Hypocalcemia caused by anticonvulsant medications
Associated Therapies
Care of the Joint, Mineral supplementation therapy, Nutritional supplementation

The Effect of Renastart Formula Supplementation in Children With Acute Kidney Injury in Maintaining Normal Serum Electrolytes Levels

Not Applicable
Completed
Conditions
Acute Kidney Injury
Interventions
First Posted Date
2024-01-23
Last Posted Date
2024-02-05
Lead Sponsor
Ain Shams University
Target Recruit Count
24
Registration Number
NCT06218212
Locations
🇪🇬

Faculty of Medicine-Ain Shams University, Cairo, Abbasia, Egypt

The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament

Phase 2
Recruiting
Conditions
Pulp Disease, Dental
Endodontic Disease
Intracanal Medication
Interventions
First Posted Date
2024-01-16
Last Posted Date
2024-01-17
Lead Sponsor
British University In Egypt
Target Recruit Count
48
Registration Number
NCT06207253
Locations
🇪🇬

British university in Egypt, Cairo, Egypt

Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication

Phase 2
Recruiting
Conditions
Endodontic Disease
Pulp Disease, Dental
Interventions
First Posted Date
2024-01-09
Last Posted Date
2024-08-19
Lead Sponsor
British University In Egypt
Target Recruit Count
54
Registration Number
NCT06196515
Locations
🇪🇬

british university in Egypt - dentistry collage, Cairo, Egypt

In Vivo Comparative Study of Calcium Hydroxide and Triple Antibiotic Paste in Intracanal Medicament in Emergency Pain Reduction

Not Applicable
Completed
Conditions
Pain
Interventions
First Posted Date
2023-12-18
Last Posted Date
2023-12-18
Lead Sponsor
Pakistan Institute of Medical Sciences
Target Recruit Count
90
Registration Number
NCT06174909
Locations
🇵🇰

School of Dentistry, Islamabad, Pakistan

The Incidence of Hypocalcemia in Pregnant Women at Siriraj Hospital

Not Applicable
Active, not recruiting
Conditions
Hypocalcemia in Pregnancy
Interventions
First Posted Date
2023-12-07
Last Posted Date
2023-12-07
Lead Sponsor
Siriraj Hospital
Target Recruit Count
444
Registration Number
NCT06160479
Locations
🇹🇭

Faculty of Medicine Siriraj Hospital, Bangkoknoi, Bangkok, Thailand

Efficacy of Oocyte Activation With Two Types of Ca2+ Ionophore.

Not Applicable
Recruiting
Conditions
Infertility, Female
Interventions
Drug: Ionomycin SIGMA
First Posted Date
2023-10-30
Last Posted Date
2024-03-13
Lead Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Target Recruit Count
44
Registration Number
NCT06106412
Locations
🇪🇸

Ivirma Valencia, Valencia, Spain

NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer

Phase 2
Active, not recruiting
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2023-10-23
Last Posted Date
2024-12-03
Lead Sponsor
Australasian Gastro-Intestinal Trials Group
Target Recruit Count
20
Registration Number
NCT06094140
Locations
🇦🇺

GenesisCare North Shore, Sydney, New South Wales, Australia

🇦🇺

Wollongong Hospital, Wollongong, New South Wales, Australia

🇦🇺

Warringal Private Hospital, Melbourne, Victoria, Australia

Biphasic Material With PRF in Lateral Sinus Floor Augmentation

Phase 1
Not yet recruiting
Conditions
Maxillary Sinus Disease
Interventions
Procedure: Lateral sinus floor augmentation
Procedure: Injectable platlets rich fibrin
First Posted Date
2023-10-06
Last Posted Date
2024-01-31
Lead Sponsor
Assiut University
Target Recruit Count
18
Registration Number
NCT06071416

Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.

Not Applicable
Not yet recruiting
Conditions
Hepatic Osteodystrophy
Liver Cirrhosis
Interventions
First Posted Date
2023-09-01
Last Posted Date
2023-09-01
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
80
Registration Number
NCT06022237
Locations
🇮🇳

Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Long-term Use of CCB and Breast Cancer Risk

Active, not recruiting
Conditions
Hypertension,Essential
Breast Cancer
Interventions
Drug: None AHT
Drug: Diuretic
Drug: Other AHT
First Posted Date
2023-08-02
Last Posted Date
2024-08-21
Lead Sponsor
Curtin University
Target Recruit Count
68500
Registration Number
NCT05972785
Locations
🇦🇺

Curtin university, Bentley, Western Australia, Australia

© Copyright 2025. All Rights Reserved by MedPath